Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionactin binding

TPM4 MYH9 MYH11 CALD1 MAP1A MICALL2 MYO7A MYO9B SYNE1 VASH1

7.16e-064797110GO:0003779
GeneOntologyMolecularFunctionmicrofilament motor activity

MYH9 MYH11 MYO7A MYO9B

9.89e-0638714GO:0000146
GeneOntologyMolecularFunctionactin filament binding

TPM4 MYH9 MYH11 MICALL2 MYO7A MYO9B SYNE1

1.60e-05227717GO:0051015
GeneOntologyMolecularFunctioncytoskeletal motor activity

MYH9 MYH11 MYO7A MYO9B DYNC1H1

6.31e-05118715GO:0003774
GeneOntologyMolecularFunctioncalmodulin binding

MYH9 MYH11 CALD1 MYO7A MYO9B KCNN1

1.68e-04230716GO:0005516
GeneOntologyMolecularFunctionnerve growth factor binding

SORT1 FURIN

3.44e-048712GO:0048406
GeneOntologyMolecularFunctionADP binding

MYH9 MYO7A MYO9B

6.64e-0448713GO:0043531
GeneOntologyMolecularFunctionU3 snoRNA binding

RRP9 PRKDC

6.72e-0411712GO:0034511
GeneOntologyMolecularFunctionneurotrophin binding

SORT1 FURIN

8.04e-0412712GO:0043121
GeneOntologyMolecularFunctionATP-dependent activity

DHX15 MYH9 MYH11 ERCC6L MYO7A MYO9B CCT2 DYNC1H1

1.48e-03614718GO:0140657
GeneOntologyCellularComponentnuclear protein-containing complex

DHX15 BMI1 PCGF6 CWF19L2 MYH9 SNW1 SUPT5H SYNE1 SUPT16H U2AF1L4 ANP32E PRKDC XRCC1 CDC5L PAF1 PABPC1 ISY1

2.58e-0613777117GO:0140513
GeneOntologyCellularComponentpost-mRNA release spliceosomal complex

DHX15 CWF19L2 ISY1

8.08e-0612713GO:0071014
GeneOntologyCellularComponentspliceosomal complex

DHX15 CWF19L2 SNW1 U2AF1L4 CDC5L PABPC1 ISY1

8.40e-06215717GO:0005681
GeneOntologyCellularComponentcontractile actin filament bundle

TPM4 MYH9 MYH11 CALD1 MICALL2

3.18e-05107715GO:0097517
GeneOntologyCellularComponentstress fiber

TPM4 MYH9 MYH11 CALD1 MICALL2

3.18e-05107715GO:0001725
GeneOntologyCellularComponenttranscription elongation factor complex

SNW1 SUPT5H SUPT16H PAF1

3.93e-0556714GO:0008023
GeneOntologyCellularComponentmyosin complex

MYH9 MYH11 MYO7A MYO9B

4.83e-0559714GO:0016459
GeneOntologyCellularComponentactomyosin

TPM4 MYH9 MYH11 CALD1 MICALL2

4.89e-05117715GO:0042641
GeneOntologyCellularComponentactin filament bundle

TPM4 MYH9 MYH11 CALD1 MICALL2

5.09e-05118715GO:0032432
GeneOntologyCellularComponentcatalytic step 2 spliceosome

SNW1 CDC5L PABPC1 ISY1

3.34e-0497714GO:0071013
GeneOntologyCellularComponentU2-type spliceosomal complex

DHX15 SNW1 CDC5L ISY1

3.34e-0497714GO:0005684
GeneOntologyCellularComponentPrp19 complex

CDC5L ISY1

1.32e-0316712GO:0000974
GeneOntologyCellularComponentactin filament

TPM4 MYH9 CALD1 MYO9B

1.54e-03146714GO:0005884
GeneOntologyCellularComponentaxon cytoplasm

MAP1A DYNC1H1 MADD

1.61e-0368713GO:1904115
GeneOntologyCellularComponentcell cortex

TPM4 MYH9 CALD1 MYO7A MYO9B DYNC1H1

1.63e-03371716GO:0005938
GeneOntologyCellularComponentPRC1 complex

BMI1 PCGF6

1.87e-0319712GO:0035102
DomainMyosin_head_motor_dom

MYH9 MYH11 MYO7A MYO9B

1.28e-0538714IPR001609
DomainMYOSIN_MOTOR

MYH9 MYH11 MYO7A MYO9B

1.28e-0538714PS51456
DomainMyosin_head

MYH9 MYH11 MYO7A MYO9B

1.28e-0538714PF00063
DomainMYSc

MYH9 MYH11 MYO7A MYO9B

1.28e-0538714SM00242
DomainHRD

UBN1 UBN2

1.42e-052712IPR014840
DomainUBN_middle_dom

UBN1 UBN2

1.42e-052712IPR026947
DomainUBN_AB

UBN1 UBN2

1.42e-052712PF14075
DomainHUN

UBN1 UBN2

1.42e-052712PF08729
DomainIQ

MYH9 MYH11 MYO7A MYO9B

1.54e-0471714PF00612
DomainIQ

MYH9 MYH11 MYO7A MYO9B

2.56e-0481714SM00015
DomainIQ_motif_EF-hand-BS

MYH9 MYH11 MYO7A MYO9B

3.83e-0490714IPR000048
DomainIQ

MYH9 MYH11 MYO7A MYO9B

4.34e-0493714PS50096
DomainMyosin_N

MYH9 MYH11

1.45e-0315712PF02736
DomainMyosin_N

MYH9 MYH11

1.45e-0315712IPR004009
DomainRhoGAP

MYO9B INPP5B ARHGAP30

1.70e-0362713SM00324
DomainRhoGAP

MYO9B INPP5B ARHGAP30

1.78e-0363713PF00620
DomainRHOGAP

MYO9B INPP5B ARHGAP30

1.86e-0364713PS50238
DomainRhoGAP_dom

MYO9B INPP5B ARHGAP30

1.86e-0364713IPR000198
Domain-

MYO9B INPP5B ARHGAP30

1.86e-03647131.10.555.10
DomainMyosin_tail_1

MYH9 MYH11

2.10e-0318712PF01576
DomainMyosin_tail

MYH9 MYH11

2.10e-0318712IPR002928
DomainMyosin-like_IQ_dom

MYH9 MYH11

2.34e-0319712IPR027401
Domain-

MYH9 MYH11

2.34e-03197124.10.270.10
DomainRRM_dom_euk

U2AF1L4 PABPC1

3.42e-0323712IPR003954
DomainRRM_1

U2AF1L4 PABPC1

3.42e-0323712SM00361
DomainRho_GTPase_activation_prot

MYO9B INPP5B ARHGAP30

4.59e-0388713IPR008936
DomainUbiquitin-rel_dom

FRMD4A PCGF6 MYO7A MYO9B

5.30e-03184714IPR029071
DomainSpectrin/alpha-actinin

SYNE1 MCF2L2

6.57e-0332712IPR018159
DomainSPEC

SYNE1 MCF2L2

6.57e-0332712SM00150
DomainFERM_N

FRMD4A MYO7A

6.97e-0333712PF09379
DomainFERM_N

FRMD4A MYO7A

6.97e-0333712IPR018979
Pubmed

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.

DHX15 MYH11 SNW1 SYNE1 EIF4G1 SUPT16H CCT2 PRKDC CDC5L PABPC1 AKAP8L DYNC1H1 ISY1 MADD

2.52e-10714731428302793
Pubmed

Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.

DHX15 MYH9 SNW1 MYO9B EIF4G1 SUPT16H ANP32E PRKDC ALDH1B1 CDC5L PABPC1 AKAP8L

4.12e-10486731230940648
Pubmed

Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.

CWF19L2 SNW1 UBN1 SUPT5H ZNF516 SUPT16H PAF1 UBN2 AKAP8L

1.02e-0922273937071664
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

DHX15 CWF19L2 SNW1 UBN1 CALD1 EIF4G1 SUPT16H U2AF1L4 PRKDC XRCC1 CDC5L PAF1 UBN2 PABPC1 ISY1

1.11e-09954731536373674
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

DHX15 TPM4 MYH9 CALD1 GYS1 EIF4G1 SUPT16H RAB2B ANP32E CCT2 PRKDC CDC5L PAF1 PABPC1 AKAP8L DYNC1H1

1.63e-091149731635446349
Pubmed

Identification of proximal SUMO-dependent interactors using SUMO-ID.

DHX15 CWF19L2 MYH9 SNW1 UBN1 CALD1 MAP1A ERCC6L EIF4G1 CDC5L UBN2

2.27e-09444731134795231
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

DHX15 SNW1 CALD1 MYO9B SUPT5H RRP9 SYNE1 EIF4G1 SUPT16H CCT2 PRKDC XRCC1 CDC5L PABPC1 DYNC1H1

2.89e-091024731524711643
Pubmed

ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.

DHX15 TPM4 MYH9 EIF4G1 SUPT16H CCT2 PRKDC PABPC1 DYNC1H1

5.29e-0926873933024031
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

DHX15 TPM4 CWF19L2 MYH9 SNW1 MAP1A SUPT5H SYNE1 GYS1 EIF4G1 SUPT16H PRKDC CDC5L AKAP8L DYNC1H1

6.05e-091082731538697112
Pubmed

Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.

TPM4 MYH9 MYH11 CALD1 EIF4G1 CCT2 PABPC1 DYNC1H1

7.08e-0919173833762435
Pubmed

TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.

DHX15 TPM4 MYH9 MYH11 CALD1 SPOUT1 SYNE1 SUPT16H CCT2 PRKDC XRCC1 CDC5L PABPC1 DYNC1H1

9.57e-09949731436574265
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

DHX15 MYH9 SNW1 SPOUT1 SUPT5H RRP9 SYNE1 SUPT16H PRKDC CDC5L PABPC1 AKAP8L DYNC1H1

1.23e-08807731322681889
Pubmed

ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.

DHX15 MYH9 CALD1 SUPT5H RRP9 EIF4G1 SUPT16H PRKDC XRCC1 CDC5L PAF1 PABPC1

1.26e-08660731232780723
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

DHX15 MYH9 SNW1 SPOUT1 SUPT5H RRP9 SUPT16H ANP32E CCT2 PRKDC ALDH1B1 CDC5L PAF1 AKAP8L

1.61e-08989731436424410
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

DHX15 PCGF6 MYH9 SNW1 UBN1 SPOUT1 MYO9B EIF4G1 SUPT16H CCT2 PRKDC ALDH1B1 CDC5L PABPC1 AKAP8L DYNC1H1

1.64e-081353731629467282
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

DHX15 MYH9 SNW1 UBN1 SUPT5H EIF4G1 SUPT16H ANP32E CCT2 PRKDC XRCC1 CDC5L PAF1 ISY1

2.19e-081014731432416067
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

DHX15 TPM4 MYH9 MYH11 DDAH1 CALD1 MAP1A MYO7A SYNE1 EIF4G1 CCT2 ALDH1B1 CDC5L PABPC1 DYNC1H1 MADD

3.57e-081431731637142655
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

SORT1 DHX15 TPM4 UBN1 CALD1 EIF4G1 SUPT16H ANP32E CCT2 PRKDC XRCC1 ALDH1B1 CDC5L UBN2 AKAP8L DYNC1H1

3.89e-081440731630833792
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

DHX15 MYH9 SNW1 MYO9B EIF4G1 U2AF1L4 CCT2 PRKDC ALDH1B1 CDC5L DCUN1D3 PABPC1 AKAP8L DYNC1H1 ISY1

3.96e-081247731527684187
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

BDP1 CWF19L2 UBN1 MAP1A MYO9B SUPT5H ZNF516 ANP32E CNTLN PAF1 UBN2

4.06e-08588731138580884
Pubmed

BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62.

DHX15 TPM4 SNW1 MAP1A CCT2 CDC5L PABPC1

4.06e-0815673732850835
Pubmed

Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.

DHX15 TPM4 MYH9 CALD1 EIF4G1 CCT2 PRKDC PABPC1

4.75e-0824473828902428
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

DHX15 MYH9 SNW1 SUPT5H EIF4G1 SUPT16H PRKDC CDC5L PAF1 PABPC1 AKAP8L

5.41e-08605731128977666
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

DHX15 TICRR PCGF6 MYH9 SNW1 UBN1 SUPT5H RRP9 SUPT16H PRKDC XRCC1 CDC5L PAF1 UBN2 ISY1

6.41e-081294731530804502
Pubmed

N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.

MYH9 CALD1 EIF4G1 PRKDC XRCC1 CDC5L NPEPL1 AKAP8L DYNC1H1

6.69e-0836073933111431
Pubmed

Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.

DHX15 TPM4 MYH9 CALD1 EIF4G1 SUPT16H PRKDC XRCC1 PABPC1 DYNC1H1 LILRB4

7.63e-08626731133644029
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

DHX15 MYH9 SNW1 RRP9 GYS1 EIF4G1 SUPT16H ANP32E CCT2 PRKDC CDC5L PAF1 PABPC1 AKAP8L DYNC1H1

8.14e-081318731530463901
Pubmed

Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.

DHX15 MYH9 SNW1 CALD1 ANP32E CCT2 CDC5L PABPC1 DYNC1H1 ISY1

1.06e-07506731030890647
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

DHX15 SNW1 CALD1 MICALL2 ERCC6L RRP9 SYNE1 EIF4G1 CCT2 PRKDC CDC5L PABPC1 AKAP8L DYNC1H1

1.09e-071155731420360068
Pubmed

Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.

TPM4 MYH9 DDAH1 EIF4G1 CCT2 PAF1 PABPC1 DYNC1H1 ISY1 MADD

1.87e-07538731028524877
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

DHX15 TPM4 MYH9 SNW1 EIF4G1 SUPT16H U2AF1L4 ANP32E CCT2 PRKDC CDC5L PAF1 PABPC1 DYNC1H1 ISY1

2.03e-071415731528515276
Pubmed

Systematic Determination of Human Cyclin Dependent Kinase (CDK)-9 Interactome Identifies Novel Functions in RNA Splicing Mediated by the DEAD Box (DDX)-5/17 RNA Helicases.

TPM4 MYH9 SNW1 EIF4G1 CCT2 PRKDC CDC5L PABPC1

2.03e-0729573826209609
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

DHX15 MYH9 SNW1 SUPT5H RRP9 SYNE1 EIF4G1 SUPT16H ANP32E CCT2 PRKDC ALDH1B1 CDC5L PABPC1 DYNC1H1

2.22e-071425731530948266
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

DHX15 TPM4 MYH9 CALD1 SUPT5H EIF4G1 SUPT16H ANP32E CCT2 PRKDC ALDH1B1 PAF1 PABPC1 DYNC1H1 SZRD1

2.90e-071455731522863883
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

DHX15 TPM4 MYH9 SNW1 SPOUT1 RRP9 EIF4G1 SUPT16H CCT2 PRKDC CDC5L PABPC1 DYNC1H1 ISY1

3.05e-071257731436526897
Pubmed

Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach.

DHX15 MYO9B CCT2 PRKDC ALDH1B1 AKAP8L DYNC1H1

3.18e-0721173717314511
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

DHX15 PCGF6 SNW1 CALD1 MAP1A SPOUT1 EIF4G1 PAF1 UBN2 PABPC1 ISY1

3.25e-07724731136232890
Pubmed

Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex.

DHX15 SUPT16H PRKDC ALDH1B1 CDC5L PAF1 AKAP8L

3.61e-0721573730462309
Pubmed

Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.

DHX15 MYH9 SNW1 EIF4G1 CCT2 PRKDC XRCC1 CDC5L PABPC1

3.70e-0744173931239290
Pubmed

DNAJC17 is localized in nuclear speckles and interacts with splicing machinery components.

DHX15 CWF19L2 MYH9 SNW1 CDC5L

4.14e-077173529773831
Pubmed

Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.

SNW1 SUPT5H GYS1 EIF4G1 CCT2 PRKDC PAF1 DYNC1H1

4.97e-0733273832786267
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

TICRR SNW1 SPOUT1 MYO9B RRP9 EIF4G1 SUPT16H PRKDC XRCC1 CDC5L AKAP8L

5.18e-07759731135915203
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

TPM4 MYH9 SNW1 CALD1 MAP1A ERCC6L ANP32E CCT2 PRKDC CDC5L PAF1 PABPC1

5.36e-07934731233916271
Pubmed

PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.

DHX15 MYH9 MYH11 CALD1 PRKDC XRCC1 CDC5L PABPC1

5.94e-0734073824332808
Pubmed

Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.

DHX15 MYH9 CCT2 PRKDC PABPC1 DYNC1H1

6.15e-0714473635681168
Pubmed

Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.

DHX15 MAP1A SUPT5H GYS1 EIF4G1 SUPT16H CCT2 PRKDC ALDH1B1 CDC5L PAF1 PABPC1 AKAP8L ISY1

6.26e-071335731429229926
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

MYH9 SNW1 SYNE1 ZNF516 EIF4G1 SUPT16H CDC5L PAF1 UBN2 PABPC1 ZEB2 DYNC1H1

7.39e-07963731228671696
Pubmed

The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.

DHX15 MYH9 MYH11 RRP9 SUPT16H U2AF1L4 CCT2 PRKDC ALDH1B1 CDC5L PAF1 PABPC1 DYNC1H1

7.44e-071153731329845934
Pubmed

Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A.

MYH9 CCT2 PRKDC PABPC1 DYNC1H1

8.53e-078273530274258
Pubmed

Targeted ubiquitination and degradation of G-protein-coupled receptor kinase 5 by the DDB1-CUL4 ubiquitin ligase complex.

DHX15 MYH9 MYO9B GYS1 PRKDC MADD

9.82e-0715673622952844
Pubmed

Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.

DHX15 TPM4 MYH9 SNW1 SUPT5H GYS1 PRKDC CDC5L PAF1 PABPC1

1.09e-06653731033742100
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

DHX15 MYH9 SNW1 SUPT5H RRP9 EIF4G1 CCT2 PRKDC PABPC1 DYNC1H1

1.09e-06653731022586326
Pubmed

Autophagic degradation of the inhibitory p53 isoform Δ133p53α as a regulatory mechanism for p53-mediated senescence.

TPM4 MYH9 CALD1 CCT2 PABPC1

1.21e-068873525144556
Pubmed

SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response.

DHX15 SNW1 RRP9 SUPT16H PRKDC CDC5L ISY1

1.26e-0625973730404004
Pubmed

Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.

TPM4 MYH9 MYH11 CALD1 MYO7A EIF4G1 CCT2 PRKDC PAF1 PABPC1 DYNC1H1

1.51e-06847731135235311
Pubmed

Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

DHX15 MYH9 SNW1 SPOUT1 RRP9 EIF4G1 PRKDC CDC5L PABPC1 AKAP8L ISY1

1.51e-06847731135850772
Pubmed

Repression of rRNA transcription by PARIS contributes to Parkinson's disease.

DHX15 MYH11 PRKDC ALDH1B1 CDC5L AKAP8L DYNC1H1

1.74e-0627273725315684
Pubmed

Identification and functional characterization of transcriptional activators in human cells.

ERCC6L SUPT5H ZNF516 CCT2 PRKDC XRCC1 ZEB2 AKAP8L

1.93e-0639873835016035
Pubmed

Fgf and Esrrb integrate epigenetic and transcriptional networks that regulate self-renewal of trophoblast stem cells.

DHX15 SUPT5H ZNF516 SUPT16H XRCC1 AKAP8L

2.05e-0617773626206133
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

SNW1 CALD1 ERCC6L CCT2 PRKDC CDC5L PAF1 UBN2 DYNC1H1

2.26e-0654973938280479
Pubmed

Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.

MYH9 SNW1 SUPT5H SUPT16H ANP32E PRKDC XRCC1

2.26e-0628373730585729
Pubmed

Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.

DHX15 MYH9 SNW1 EIF4G1 CCT2 PRKDC CDC5L PABPC1 AKAP8L

2.33e-0655173934728620
Pubmed

Identification of Human Neuronal Protein Complexes Reveals Biochemical Activities and Convergent Mechanisms of Action in Autism Spectrum Disorders.

DHX15 EIF4G1 CCT2 PRKDC AKAP8L

2.40e-0610173526949739
Pubmed

BMI1-UBR5 axis regulates transcriptional repression at damaged chromatin.

BMI1 SUPT5H SUPT16H

2.50e-061373327647897
Pubmed

Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.

DHX15 MYH9 EIF4G1 CCT2 PRKDC ALDH1B1 CDC5L PABPC1 AKAP8L DYNC1H1

2.77e-06725731027025967
Pubmed

Nucleolar proteome dynamics.

MYH9 SNW1 RRP9 ANP32E CCT2 PRKDC XRCC1 DYNC1H1

2.82e-0641973815635413
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

DHX15 SNW1 ZNF516 ANP32E CCT2 PRKDC XRCC1 PAF1 UBN2 PABPC1 ZEB2 DYNC1H1

3.02e-061103731234189442
Pubmed

RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.

DHX15 MYH9 SUPT16H CCT2 PRKDC CDC5L PABPC1 DYNC1H1

3.13e-0642573821081503
Pubmed

UHRF2 commissions the completion of DNA demethylation through allosteric activation by 5hmC and K33-linked ubiquitination of XRCC1.

SUPT16H PRKDC XRCC1

3.18e-061473334111398
Pubmed

Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.

MYH9 MYO7A MYO9B

3.18e-06147338022818
Pubmed

LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.

DHX15 TPM4 MYH9 MYH11 CALD1 EIF4G1 CCT2 PABPC1 DYNC1H1

3.53e-0658073935676659
Pubmed

In vitro nuclear interactome of the HIV-1 Tat protein.

DHX15 MYH9 SUPT16H CDC5L PAF1 PABPC1

3.58e-0619573619454010
Pubmed

The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.

DHX15 PCGF6 SNW1 SUPT16H CCT2 PRKDC CDC5L PAF1 AKAP8L

3.68e-0658373929844126
Pubmed

Poly(A) binding protein abundance regulates eukaryotic translation initiation factor 4F assembly in human cytomegalovirus-infected cells.

EIF4G1 PABPC1

4.35e-06273222431630
Pubmed

Association between polymorphisms in DNA repair genes (XRCC1 and XRCC7) and risk of preeclampsia.

PRKDC XRCC1

4.35e-06273222825692
Pubmed

Epstein-Barr Virus Protein EB2 Stimulates Translation Initiation of mRNAs through Direct Interactions with both Poly(A)-Binding Protein and Eukaryotic Initiation Factor 4G.

EIF4G1 PABPC1

4.35e-06273229142127
Pubmed

Recognition of eIF4G by rotavirus NSP3 reveals a basis for mRNA circularization.

EIF4G1 PABPC1

4.35e-06273212086624
Pubmed

UBN1/2 of HIRA complex is responsible for recognition and deposition of H3.3 at cis-regulatory elements of genes in mouse ES cells.

UBN1 UBN2

4.35e-06273230285846
Pubmed

A mechanism of translational repression by competition of Paip2 with eIF4G for poly(A) binding protein (PABP) binding.

EIF4G1 PABPC1

4.35e-06273216772376
Pubmed

XRCC1 is phosphorylated by DNA-dependent protein kinase in response to DNA damage.

PRKDC XRCC1

4.35e-06273216397295
Pubmed

Interdomain allostery promotes assembly of the poly(A) mRNA complex with PABP and eIF4G.

EIF4G1 PABPC1

4.35e-06273223041282
Pubmed

LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.

MYH9 MYH11 MYO9B EIF4G1 SUPT16H PRKDC

4.39e-0620273633005030
Pubmed

A new role for FBP21 as regulator of Brr2 helicase activity.

DHX15 SNW1 ISY1

4.87e-061673328838205
Pubmed

Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production.

SUPT16H ANP32E PRKDC CDC5L PABPC1 DYNC1H1

4.91e-0620673622174317
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

DHX15 TPM4 MYH9 MYH11 SNW1 SPOUT1 EIF4G1 SUPT16H RAB2B DCUN1D3 PABPC1 AKAP8L DYNC1H1

5.00e-061371731336244648
Pubmed

A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.

TPM4 MYH11 CALD1 EIF4G1 U2AF1L4

5.16e-0611873530979931
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

ERICH1 CCDC71L BMI1 PCGF6 UBN1 SUPT16H XRCC1 UBN2 ZEB2

5.16e-0660873936089195
Pubmed

Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells.

TPM4 MYH9 MYH11 CNTLN

5.22e-065473422266860
Pubmed

LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.

DHX15 MYH9 MYH11 SUPT16H CCT2 PRKDC PABPC1

5.83e-0632773731409639
Pubmed

SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.

DHX15 MYH9 SYNE1 CCT2 PRKDC PAF1 PABPC1 DYNC1H1

5.86e-0646373834901782
Pubmed

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

MYH9 UBN1 MYO9B EIF4G1 SUPT16H PRKDC DYNC1H1

6.44e-0633273737433992
Pubmed

NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90.

DHX15 MYH9 CALD1 SYNE1 PRKDC PABPC1 DYNC1H1

6.57e-0633373732665550
Pubmed

Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN.

DHX15 TPM4 MYH9 SUPT16H CCT2 PRKDC DYNC1H1

6.70e-0633473730425250
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

DHX15 MYH9 MYH11 SPNS2 SYNE1 EIF4G1 CCT2 PRKDC PABPC1 DYNC1H1

7.11e-06807731030575818
Pubmed

Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.

DHX15 MYH9 SNW1 EIF4G1 ANP32E CCT2 PRKDC CDC5L PABPC1 DYNC1H1

7.27e-06809731032129710
Pubmed

GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system.

DHX15 EIF4G1 CCT2 PRKDC CDC5L DYNC1H1

7.34e-0622173629991511
Pubmed

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

DHX15 ERCC6L EIF4G1 SUPT16H CCT2 PRKDC CDC5L PABPC1 DYNC1H1

7.59e-0663873933239621
Pubmed

Human transcription factor protein interaction networks.

TPM4 PCGF6 SNW1 UBN1 ZNF516 EIF4G1 CCT2 XRCC1 UBN2 PABPC1 ZEB2 AKAP8L DYNC1H1

7.81e-061429731335140242
Pubmed

Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.

MYH9 SNW1 RRP9 EIF4G1 SUPT16H ANP32E CCT2 PRKDC PABPC1

7.88e-0664173936057605
Pubmed

The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.

MYH9 SPOUT1 RRP9 SUPT16H CCT2 PRKDC AKAP8L DYNC1H1

7.96e-0648373836912080
InteractionSLX4 interactions

DHX15 CWF19L2 SNW1 UBN1 SUPT5H ZNF516 SUPT16H CCT2 PRKDC PAF1 UBN2 ZEB2 AKAP8L DYNC1H1

1.49e-085727314int:SLX4
InteractionCSNK2A1 interactions

DHX15 BDP1 BMI1 PCGF6 MYH9 CALD1 SUPT5H RRP9 GYS1 SUPT16H CCT2 PRKDC XRCC1 CDC5L PAF1 PABPC1 ZEB2

3.89e-089567317int:CSNK2A1
InteractionCSNK2B interactions

ERICH1 BMI1 PCGF6 CWF19L2 SPOUT1 SUPT5H ZNF516 SUPT16H XRCC1 CDC5L PAF1 ZEB2 DYNC1H1 MADD

4.50e-086257314int:CSNK2B
InteractionSRRM1 interactions

DHX15 BMI1 SNW1 CALD1 SPOUT1 SUPT16H PRKDC CDC5L PAF1 DYNC1H1 ISY1

4.76e-083487311int:SRRM1
InteractionH3C1 interactions

BMI1 PCGF6 MYH9 SNW1 UBN1 MICALL2 SYNE1 EIF4G1 SUPT16H ANP32E CCT2 PRKDC XRCC1 PAF1 UBN2 DYNC1H1

1.07e-079017316int:H3C1
InteractionCIT interactions

DHX15 TPM4 MYH9 MYH11 SNW1 SPOUT1 MYO9B SUPT5H RRP9 SYNE1 EIF4G1 SUPT16H CCT2 PRKDC XRCC1 CDC5L PAF1 PABPC1 AKAP8L DYNC1H1

1.30e-0714507320int:CIT
InteractionCUL7 interactions

DHX15 TPM4 SNW1 CALD1 MAP1A SUPT5H RRP9 EIF4G1 SUPT16H CCT2 PRKDC XRCC1 CDC5L PABPC1 DYNC1H1

2.88e-078457315int:CUL7
InteractionSMC5 interactions

DHX15 CWF19L2 MYH9 SNW1 UBN1 CALD1 EIF4G1 SUPT16H U2AF1L4 PRKDC XRCC1 CDC5L PAF1 UBN2 PABPC1 ISY1

4.38e-0710007316int:SMC5
InteractionCEBPB interactions

DHX15 TPM4 TICRR MYH9 SUPT5H EIF4G1 SUPT16H ANP32E CCT2 PRKDC XRCC1 ALDH1B1 CDC5L PAF1 PABPC1 ZEB2 AKAP8L DYNC1H1 ISY1

5.93e-0714437319int:CEBPB
InteractionMECOM interactions

DHX15 ZNF516 SUPT16H CCT2 PRKDC ALDH1B1 CDC5L PAF1 AKAP8L DYNC1H1

6.35e-073587310int:MECOM
InteractionPPIE interactions

DHX15 BMI1 CWF19L2 SNW1 U2AF1L4 CDC5L PABPC1 DYNC1H1 ISY1

8.03e-07282739int:PPIE
InteractionFGD5 interactions

TPM4 MYH9 MYH11 CALD1 EIF4G1 CCT2 PABPC1 DYNC1H1

8.21e-07207738int:FGD5
InteractionPLRG1 interactions

BMI1 CWF19L2 SNW1 PRKDC CDC5L PABPC1 DYNC1H1 ISY1

1.13e-06216738int:PLRG1
InteractionCDC5L interactions

DHX15 CWF19L2 MYH9 SNW1 UBN1 ERCC6L SUPT5H SYNE1 CCT2 PRKDC CDC5L PABPC1 DYNC1H1 ISY1

1.98e-068557314int:CDC5L
InteractionMECP2 interactions

DHX15 TPM4 CWF19L2 MYH9 SNW1 MAP1A SPOUT1 SUPT5H SYNE1 GYS1 EIF4G1 SUPT16H PRKDC CDC5L AKAP8L DYNC1H1 ISY1

2.55e-0612877317int:MECP2
InteractionEED interactions

DHX15 TPM4 BMI1 PCGF6 MYH9 MYH11 SPOUT1 SUPT5H RRP9 ZNF516 EIF4G1 SUPT16H CCT2 PRKDC XRCC1 CDC5L PABPC1 DYNC1H1

2.79e-0614457318int:EED
InteractionBRD7 interactions

DHX15 MYH9 SNW1 MYO9B EIF4G1 SUPT16H ANP32E PRKDC ALDH1B1 CDC5L PABPC1 AKAP8L

2.83e-066377312int:BRD7
InteractionEFTUD2 interactions

DHX15 TPM4 BMI1 CWF19L2 MYH9 SNW1 SUPT5H EIF4G1 SUPT16H U2AF1L4 ANP32E CCT2 PRKDC CDC5L PAF1 PABPC1 DYNC1H1 ISY1

2.90e-0614497318int:EFTUD2
InteractionECT2 interactions

DHX15 TPM4 CWF19L2 MYH9 MYH11 RRP9 SUPT16H PRKDC ALDH1B1 CDC5L PABPC1 AKAP8L DYNC1H1 MADD

3.03e-068877314int:ECT2
InteractionCBX3 interactions

ERICH1 CCDC71L BMI1 PCGF6 CWF19L2 SNW1 SUPT5H SUPT16H ANP32E XRCC1 ALDH1B1 UBN2

3.27e-066467312int:CBX3
InteractionBAP1 interactions

DHX15 TPM4 MYH9 CALD1 MYO9B GYS1 EIF4G1 SUPT16H RAB2B ANP32E CCT2 PRKDC CDC5L PAF1 PABPC1 AKAP8L DYNC1H1

3.38e-0613147317int:BAP1
InteractionBAG5 interactions

DHX15 TPM4 MYH9 SNW1 MAP1A TLE2 CCT2 CDC5L PABPC1

3.83e-06341739int:BAG5
InteractionPML interactions

DHX15 CWF19L2 MYH9 SNW1 UBN1 CALD1 MAP1A ERCC6L ZNF516 EIF4G1 XRCC1 CDC5L PAF1 UBN2

5.44e-069337314int:PML
InteractionNUPR1 interactions

DHX15 MYH9 CALD1 SUPT5H RRP9 EIF4G1 SUPT16H PRKDC XRCC1 CDC5L PAF1 PABPC1

5.77e-066837312int:NUPR1
InteractionCHD4 interactions

DHX15 BMI1 PCGF6 MYH9 SNW1 SUPT5H EIF4G1 SUPT16H PRKDC CDC5L PAF1 PABPC1 AKAP8L ISY1

5.78e-069387314int:CHD4
InteractionCDK9 interactions

TPM4 MYH9 SNW1 SUPT5H EIF4G1 SUPT16H CCT2 PRKDC ALDH1B1 CDC5L PAF1 PABPC1

5.94e-066857312int:CDK9
InteractionDDX39B interactions

DHX15 BMI1 MYH9 SNW1 SUPT5H SUPT16H CCT2 PRKDC CDC5L PABPC1 DYNC1H1

6.12e-065707311int:DDX39B
InteractionSF3A1 interactions

DHX15 MYH9 SNW1 SYNE1 EIF4G1 SUPT16H CDC5L PABPC1 DYNC1H1 ISY1

7.36e-064717310int:SF3A1
InteractionILF2 interactions

DHX15 TPM4 BMI1 MICALL2 SUPT5H ZFR2 PRKDC CDC5L PABPC1 DYNC1H1 ISY1

8.47e-065907311int:ILF2
InteractionSNRPA interactions

DHX15 SNW1 SUPT5H SUPT16H PRKDC CDC5L PAF1 PABPC1 DYNC1H1 ISY1

9.00e-064827310int:SNRPA
InteractionSNRPD3 interactions

DHX15 BDP1 CWF19L2 SNW1 PRKDC CDC5L PABPC1 DYNC1H1 ISY1

9.18e-06380739int:SNRPD3
InteractionSNRPF interactions

DHX15 ERICH1 CWF19L2 SNW1 SUPT5H CDC5L PAF1 PABPC1 ISY1

1.02e-05385739int:SNRPF
InteractionISG15 interactions

DHX15 TPM4 MYH9 CALD1 EIF4G1 SUPT16H CCT2 PRKDC PABPC1 DYNC1H1

1.11e-054947310int:ISG15
InteractionPPIL1 interactions

BMI1 CWF19L2 SNW1 CDC5L PABPC1 ISY1

1.55e-05147736int:PPIL1
InteractionFUS interactions

DHX15 BMI1 SNW1 MICALL2 SUPT5H RRP9 CCT2 PRKDC CDC5L PAF1 PABPC1 DYNC1H1

1.62e-057577312int:FUS
InteractionTMPO interactions

DHX15 TPM4 BMI1 MYH9 SNW1 CALD1 EIF4G1 CCT2 PRKDC CDC5L PABPC1 AKAP8L

1.73e-057627312int:TMPO
InteractionSNRNP40 interactions

CWF19L2 SNW1 UBN1 SUPT5H SUPT16H CCT2 XRCC1 CDC5L PAF1 UBN2 ISY1

1.73e-056377311int:SNRNP40
InteractionSNRPD2 interactions

DHX15 ERICH1 MYH9 SNW1 SUPT16H PRKDC CDC5L PABPC1 DYNC1H1

1.81e-05414739int:SNRPD2
InteractionOBSL1 interactions

DHX15 DDAH1 SNW1 CALD1 SUPT5H RRP9 SYNE1 SUPT16H CCT2 PRKDC CDC5L PABPC1 DYNC1H1

1.89e-059027313int:OBSL1
InteractionRBM39 interactions

DHX15 MYH11 SNW1 SYNE1 EIF4G1 SUPT16H CCT2 PRKDC CDC5L PABPC1 AKAP8L DYNC1H1 ISY1 MADD

1.90e-0510427314int:RBM39
InteractionKIF20A interactions

DHX15 TPM4 MYH9 MYH11 RRP9 INPP5B SYNE1 MCF2L2 SUPT16H PRKDC ALDH1B1 PABPC1 ZEB2 AKAP8L

2.11e-0510527314int:KIF20A
InteractionUBR5 interactions

DHX15 TPM4 BMI1 SNW1 SPOUT1 SUPT5H SUPT16H PRKDC CDC5L PABPC1

2.14e-055337310int:UBR5
InteractionMCM2 interactions

DHX15 TPM4 MYH9 UBN1 MYO9B SYNE1 EIF4G1 SUPT16H CCT2 PRKDC PAF1 UBN2 PABPC1 DYNC1H1

2.85e-0510817314int:MCM2
InteractionDOT1L interactions

DHX15 MYH9 SNW1 SPOUT1 SUPT5H RRP9 EIF4G1 PRKDC CDC5L PABPC1 AKAP8L ISY1

3.04e-058077312int:DOT1L
InteractionKCTD13 interactions

DHX15 TPM4 MYH9 MYH11 DDAH1 CALD1 MAP1A MYO7A SYNE1 EIF4G1 CCT2 ALDH1B1 CDC5L PABPC1 DYNC1H1 MADD

3.08e-0513947316int:KCTD13
InteractionNR2C2 interactions

DHX15 MYH9 SNW1 UBN1 RRP9 GYS1 EIF4G1 SUPT16H ANP32E CCT2 PRKDC CDC5L PAF1 PABPC1 AKAP8L DYNC1H1

3.33e-0514037316int:NR2C2
InteractionRIOK1 interactions

DHX15 MYH9 SNW1 SUPT5H SUPT16H CCT2 PRKDC CDC5L PABPC1 DYNC1H1

3.37e-055627310int:RIOK1
InteractionCHD1L interactions

SNW1 SUPT16H PRKDC XRCC1 CDC5L

3.44e-05102735int:CHD1L
InteractionUSB1 interactions

CWF19L2 SNW1 CDC5L ISY1

3.48e-0551734int:USB1
InteractionPRPF19 interactions

DHX15 CWF19L2 SNW1 TLE2 PRKDC CDC5L PABPC1 DYNC1H1 ISY1

3.49e-05450739int:PRPF19
InteractionRPA4 interactions

SNW1 ERCC6L SUPT5H EIF4G1 SUPT16H RAB2B CCT2 CDC5L PABPC1

3.61e-05452739int:RPA4
InteractionACTC1 interactions

DHX15 MYH9 SNW1 CALD1 SYNE1 ANP32E CCT2 CDC5L PABPC1 DYNC1H1 ISY1

3.80e-056947311int:ACTC1
InteractionGARIN4 interactions

GARIN4 RAB2B

3.87e-053732int:GARIN4
InteractionH2BC21 interactions

DHX15 TICRR CWF19L2 SUPT5H SUPT16H ANP32E ARHGAP30 PRKDC XRCC1 PAF1 DYNC1H1

3.90e-056967311int:H2BC21
InteractionSOX2 interactions

DHX15 BMI1 FRMD4A MAP1A MYO9B SUPT5H RRP9 SUPT16H ANP32E CCT2 CNTLN XRCC1 PAF1 UBN2 ZEB2 AKAP8L

3.92e-0514227316int:SOX2
InteractionPRC1 interactions

DHX15 BDP1 MYH9 SNW1 RRP9 SYNE1 SUPT16H ANP32E CCT2 PRKDC CDC5L PABPC1 DYNC1H1

4.17e-059737313int:PRC1
InteractionNAA40 interactions

TPM4 MYH9 SNW1 CALD1 MAP1A ERCC6L SUPT16H ANP32E CCT2 PRKDC CDC5L PAF1 PABPC1

4.39e-059787313int:NAA40
InteractionRANBP2 interactions

DHX15 BMI1 CWF19L2 RSAD2 SNW1 SUPT16H PRKDC CDC5L

4.78e-05361738int:RANBP2
InteractionPPP1CB interactions

DHX15 TPM4 MYH9 SNW1 CALD1 MICALL2 GYS1 EIF4G1 DYNC1H1

4.81e-05469739int:PPP1CB
InteractionIQGAP1 interactions

DHX15 TPM4 BMI1 MYH9 SNW1 EIF4G1 CCT2 CDC5L PABPC1 DYNC1H1

5.14e-055917310int:IQGAP1
InteractionSUMO2 interactions

SNW1 SUPT5H GYS1 EIF4G1 SUPT16H CCT2 PRKDC PAF1 NPEPL1 DYNC1H1

5.14e-055917310int:SUMO2
InteractionGRK5 interactions

DHX15 MYH9 MYO9B GYS1 PRKDC MADD

5.15e-05182736int:GRK5
InteractionDDX23 interactions

BMI1 CWF19L2 SNW1 SUPT5H SYNE1 SUPT16H ANP32E CDC5L PAF1

5.75e-05480739int:DDX23
InteractionELAVL2 interactions

BMI1 CWF19L2 SNW1 CDC5L PABPC1 ISY1

6.17e-05188736int:ELAVL2
InteractionPOLR1G interactions

CWF19L2 SUPT5H ZNF516 SUPT16H ANP32E XRCC1 PAF1 UBN2 ZEB2

6.63e-05489739int:POLR1G
InteractionCUL1 interactions

DHX15 MYH9 SNW1 GYS1 CCT2 CCDC168 PRKDC XRCC1 CDC5L DCUN1D3 PABPC1 AKAP8L

6.73e-058767312int:CUL1
InteractionKIAA1143 interactions

DHX15 SNW1 CDC5L ISY1

7.07e-0561734int:KIAA1143
InteractionBIRC3 interactions

DHX15 MYH9 SNW1 SUPT5H RRP9 SYNE1 EIF4G1 SUPT16H ANP32E CCT2 PRKDC ALDH1B1 CDC5L PABPC1 DYNC1H1

7.22e-0513347315int:BIRC3
InteractionMEX3A interactions

MYH9 UBN1 MYO9B EIF4G1 SUPT16H PRKDC PABPC1 DYNC1H1

7.37e-05384738int:MEX3A
InteractionSEC31B interactions

BMI1 SNW1 CCT2

7.67e-0523733int:SEC31B
InteractionPPP5D1P interactions

MYH9 MYH11

7.73e-054732int:PPP5D1P
InteractionWDR83 interactions

FRMD4A CWF19L2 SNW1 CCT2 CDC5L ISY1

7.77e-05196736int:WDR83
InteractionCALM1 interactions

TPM4 BMI1 MYH9 DDAH1 SNW1 CALD1 MYO7A MYO9B KCNN1 CDC5L

8.30e-056267310int:CALM1
InteractionCHD3 interactions

DHX15 BMI1 MYH9 SNW1 SUPT5H EIF4G1 SUPT16H PRKDC CDC5L PABPC1 AKAP8L

8.31e-057577311int:CHD3
InteractionMST1R interactions

TPM4 CALD1 SYNE1 CCDC168 PRKDC DYNC1H1

8.68e-05200736int:MST1R
InteractionAURKB interactions

DHX15 TPM4 BMI1 MYH9 MYH11 SNW1 CCT2 PRKDC CDC5L PABPC1 DYNC1H1

8.71e-057617311int:AURKB
InteractionCAPZB interactions

DHX15 TPM4 BMI1 MYH9 MYH11 CALD1 EIF4G1 CCT2 CDC5L UBN2 PABPC1 AKAP8L DYNC1H1

8.97e-0510497313int:CAPZB
InteractionLRRC31 interactions

MYH9 MYH11 MYO9B EIF4G1 SUPT16H PRKDC

9.94e-05205736int:LRRC31
InteractionSNRPB interactions

DHX15 BMI1 CWF19L2 SNW1 SUPT5H CDC5L PAF1 DYNC1H1 ISY1

1.01e-04517739int:SNRPB
InteractionTNIP1 interactions

DHX15 TPM4 MYH9 MYH11 CALD1 SPOUT1 SYNE1 SUPT16H CCT2 PRKDC XRCC1 CDC5L PABPC1 DYNC1H1

1.03e-0412177314int:TNIP1
InteractionPRPF8 interactions

DHX15 BMI1 SNW1 SUPT5H SUPT16H CCT2 PRKDC CDC5L PABPC1 DYNC1H1 ISY1

1.04e-047767311int:PRPF8
InteractionPRKACA interactions

MYH9 CALD1 GYS1 CCT2 PRKDC PABPC1 ADCY5 AKAP8L DYNC1H1

1.04e-04519739int:PRKACA
InteractionSNRPA1 interactions

DHX15 CWF19L2 SNW1 PRKDC CDC5L DYNC1H1 ISY1

1.06e-04300737int:SNRPA1
InteractionACIN1 interactions

DHX15 BMI1 SNW1 SUPT5H FURIN SUPT16H PRKDC

1.08e-04301737int:ACIN1
InteractionFLNA interactions

TPM4 MYH9 MYH11 SNW1 CALD1 TLE2 FURIN PRKDC PABPC1 DYNC1H1

1.10e-046487310int:FLNA
InteractionU2AF2 interactions

DHX15 MYH9 SNW1 MICALL2 EIF4G1 CCT2 PRKDC CDC5L PABPC1 DYNC1H1

1.15e-046517310int:U2AF2
InteractionCWC15 interactions

SNW1 PRKDC CDC5L DYNC1H1 ISY1

1.26e-04134735int:CWC15
InteractionDNAJC17 interactions

PCGF6 CWF19L2 SNW1 CDC5L ISY1

1.26e-04134735int:DNAJC17
InteractionBMI1 interactions

BMI1 PCGF6 SNW1 SYNE1 EIF4G1 SUPT16H CCT2 PRKDC AKAP8L DYNC1H1

1.27e-046597310int:BMI1
InteractionSYF2 interactions

CWF19L2 SNW1 CDC5L ISY1

1.28e-0471734int:SYF2
InteractionSNIP1 interactions

DHX15 SNW1 RRP9 GYS1 SUPT16H PRKDC CDC5L ISY1

1.30e-04417738int:SNIP1
InteractionISY1 interactions

TPM4 CWF19L2 SNW1 CDC5L ISY1

1.31e-04135735int:ISY1
InteractionBTF3 interactions

DHX15 TPM4 MYH9 CALD1 EIF4G1 SUPT16H PRKDC XRCC1 PABPC1 DYNC1H1 LILRB4

1.34e-047997311int:BTF3
InteractionUSP11 interactions

SORT1 DHX15 TPM4 BMI1 MYH9 SUPT16H CCT2 ALDH1B1 DYNC1H1

1.39e-04539739int:USP11
InteractionNCAPH interactions

MYH9 SNW1 EIF4G1 XRCC1 CDC5L PABPC1 DYNC1H1

1.44e-04315737int:NCAPH
InteractionWDR5 interactions

DHX15 BMI1 PCGF6 MYH9 SNW1 RRP9 EIF4G1 SUPT16H CCT2 PRKDC ALDH1B1 PABPC1 DYNC1H1

1.46e-0411017313int:WDR5
InteractionCIC interactions

DHX15 PCGF6 SNW1 SUPT5H SUPT16H CCT2 PRKDC CDC5L PAF1 AKAP8L

1.50e-046737310int:CIC
InteractionCWF19L1 interactions

CWF19L2 SNW1 CDC5L ISY1

1.50e-0474734int:CWF19L1
InteractionACE2 interactions

TPM4 MYH9 SNW1 CALD1 RRP9 EIF4G1 SUPT16H ANP32E CCT2 PRKDC XRCC1 PABPC1 DYNC1H1

1.52e-0411067313int:ACE2
InteractionCDCA5 interactions

DHX15 BDP1 PCGF6 PRKDC PABPC1

1.55e-04140735int:CDCA5
Cytoband19p13.1

TPM4 MYO9B KCNN1

6.34e-054873319p13.1
Cytoband10q24.33

PCGF6 CALHM1

1.63e-041273210q24.33
Cytoband3q21.1

ADCY5 PARP15

4.65e-04207323q21.1
Cytoband11q13.5

MYO7A GVQW3

5.14e-042173211q13.5
CytobandEnsembl 112 genes in cytogenetic band chr19p13

TPM4 MYO9B TLE2 ZFR2 KCNN1 AKAP8L

1.71e-03797736chr19p13
CytobandEnsembl 112 genes in cytogenetic band chr3q21

ADCY5 ISY1 PARP15

2.16e-03160733chr3q21
CytobandEnsembl 112 genes in cytogenetic band chr19q13

SUPT5H GYS1 U2AF1L4 TMC4 XRCC1 PAF1 LILRB4

2.87e-031192737chr19q13
Cytoband15q26.1

TICRR FURIN

3.38e-035473215q26.1
GeneFamilyRing finger proteins|Polycomb group ring fingers

BMI1 PCGF6

1.21e-04744261
GeneFamilyMyosin heavy chains

MYH9 MYH11

5.96e-04154421098
GeneFamilyAnkyrin repeat domain containing|FERM domain containing

FRMD4A MYO7A

6.58e-03504421293
GeneFamilyGATA zinc finger domain containing|Myb/SANT domain containing

BDP1 CDC5L

7.37e-0353442532
CoexpressionWANG_TUMOR_INVASIVENESS_UP

CALD1 SPOUT1 SUPT5H EIF4G1 CCT2 PAF1 PABPC1 SZRD1

1.16e-05384738M1865
CoexpressionWANG_TUMOR_INVASIVENESS_UP

CALD1 SPOUT1 SUPT5H EIF4G1 CCT2 PAF1 PABPC1 SZRD1

1.61e-05402738MM1248
ToppCell(5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)

SORT1 DHX15 MYH9 MYH11 CALD1 SH3BGR ADCY5

3.42e-08196737541b1fcf509e362f6f48720046cb5378aaf7c591
ToppCell390C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SORT1 TPM4 MYH9 MYH11 CALD1 SH3BGR ALDH1B1

3.92e-082007372bc7f462a551292de2501028164573935232f899
ToppCell390C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SORT1 TPM4 MYH9 MYH11 CALD1 SH3BGR ALDH1B1

3.92e-082007378b80a65b69b36ed405214564b939452c90aa40d6
ToppCellLA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

SORT1 TPM4 MYH9 MYH11 DDAH1 CALD1

6.84e-071897366b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCellP28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MYH11 CALD1 MAP1A SH3BGR ADCY5 ZEB2

7.50e-0719273687c7780cf72f4c204f2a5f6655309d47a23c08ae
ToppCellFibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id

DHX15 FRMD4A MYH9 MYH11 CALD1 ADCY5

8.21e-07195736c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1
ToppCellPericytes|World / shred by cell class for parenchyma

DHX15 MYH11 CALD1 SH3BGR ALDH1B1 ADCY5

8.45e-071967368e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e
ToppCell356C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SORT1 MYH9 MYH11 SH3BGR ALDH1B1 ADCY5

8.71e-0719773671367bebc23d0e81f60f780d6b0ab3a1783ac014
ToppCell356C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

SORT1 MYH9 MYH11 SH3BGR ALDH1B1 ADCY5

8.71e-071977360f9836554ace3f9d155ebafdd719aa26466ca44e
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

FRMD4A MYH11 CALD1 MAP1A SYNE1 ADCY5

9.51e-072007369169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

MYH11 CALD1 SYNE1 CNTLN ADCY5 ZEB2

9.51e-0720073608bf8c00eee6468215edb3611296bfc8784c4d56
ToppCellLPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type

MYH11 CALD1 MAP1A SYNE1 ADCY5 ZEB2

9.51e-072007368bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FRMD4A CALD1 SYNE1 MCF2L2 ZEB2

6.40e-061597355ca96db4281abb5f646150ccf36adc66ab201c78
ToppCellRV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

TPM4 MYH11 DDAH1 CALD1 ISY1

6.60e-0616073529c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FRMD4A CALD1 SYNE1 MCF2L2 ZEB2

8.86e-06170735876b84740e15399bfff2b9c7f0b80fd759bbdb3f
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FRMD4A CALD1 SYNE1 MCF2L2 ZEB2

8.86e-061707351f8738acf439d893880db7e1fdc9b3615ca00c39
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH11 CALD1 ERCC6L SH3BGR ADCY5

9.92e-061747359f2e253694eb5860c00528fda31c305c6de8a2a1
ToppCelldroplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SORT1 FRMD4A MYO7A FURIN LILRB4

1.05e-05176735e74ad0db3b05897edcfabeb11008ede2b9eeb638
ToppCelldroplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SORT1 FRMD4A MYO7A FURIN LILRB4

1.08e-0517773571919b5c9bfa87fdd2cd44dfa057b66ea081be5d
ToppCellfacs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORT1 MYH11 INPP5B SH3BGR ADCY5

1.14e-051797358da6863edc756540bb097cc7221c1408640d9bb4
ToppCellCOVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type

TPM4 FRMD4A MYH11 CALD1 ADCY5

1.14e-05179735111b1084f73306bdeffaaf240e7dbb4f5bf33de1
ToppCellfacs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORT1 MYH11 INPP5B SH3BGR ADCY5

1.14e-05179735f39c13c99a07d009cc677e363ffe089089c64916
ToppCellCOVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type

SORT1 TPM4 FRMD4A MYH11 CALD1

1.14e-05179735a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32

DHX15 TICRR SUPT16H ANP32E PABPC1

1.17e-0518073544988c34861df359a68376500c42a64fbcc4b431
ToppCelldroplet-Kidney-nan-18m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH11 CALD1 MAP1A SH3BGR ADCY5

1.17e-05180735b6f44fdedc33b7d93b0074e8e9c8cc32009d4c4d
ToppCellfacs-Heart-RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CCDC71L KCNC2 ARHGAP30 ZEB2 LILRB4

1.23e-051827358292e8e8474c930ffb88cbab4f6ebdb6f58db645
ToppCellPericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

MYH11 CALD1 MAP1A CCDC168 COLGALT2

1.27e-05183735d04deef7cd4e1738227a6593b84874ce0168c773
ToppCellfacs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORT1 MYH11 CALD1 SH3BGR ADCY5

1.27e-051837358d45dff06a199b1369576657f7f9dc0249c5f841
ToppCellfacs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORT1 MYH11 CALD1 SH3BGR ADCY5

1.27e-05183735421265fa15d5a028cb567bb0904e670473ef102b
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FRMD4A MYH11 CALD1 SYNE1 ADCY5

1.37e-051867354780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCellP07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MYH11 CALD1 MAP1A SH3BGR ADCY5

1.44e-051887356ec22b79b19d57ea187f312907819dc2d01f3efe
ToppCelldroplet-Kidney-nan-3m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH11 CALD1 MAP1A SH3BGR ADCY5

1.48e-05189735a959c9d6a0866582688a4204d625c1e5a123e93d
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TPM4 MYH11 CALD1 SH3BGR ALDH1B1

1.56e-05191735d35692c652977500a3c36aa26c347a072b71e441
ToppCellControl-Stromal-SMC|Stromal / Disease state, Lineage and Cell class

SORT1 MYH9 MYH11 CALD1 ADCY5

1.56e-051917352da83c493e60ad0278848957645277d76737a188
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TPM4 MYH11 CALD1 SH3BGR ALDH1B1

1.56e-051917352a107e9096eb58b81b3da61547904d85754f6b2f
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH11 CALD1 MAP1A SH3BGR ADCY5

1.59e-0519273526d9207e72bbef5e0046de511e2c9ff752b726f3
ToppCellPND07|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM4 MYH11 CALD1 ARHGAP30 ZEB2

1.59e-051927358171a60df481195c39a7f740effcae8e4deb6ca7
ToppCelldroplet-Kidney-nan-3m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH11 CALD1 MAP1A SH3BGR ADCY5

1.59e-051927353617d2bc7e33d981f3ec349e9962d8d4bd822fbd
ToppCellP15-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

MYH11 CALD1 MAP1A SH3BGR ADCY5

1.59e-05192735a476895b7b252c388d6346eacbc72f0115b1443e
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH11 CALD1 MAP1A SH3BGR ADCY5

1.63e-051937359a2c1711dec9dd8c8313bcf25bb888ac8e86c3f3
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORT1 MYH11 CALD1 SH3BGR ADCY5

1.63e-051937351043b28503bfaa0d5a82ec358bc86cbde73ea8f2
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH11 CALD1 MAP1A SH3BGR ADCY5

1.63e-051937357fc3ab7261c88c1df71744bf5b17e8e46c4300e0
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH11 CALD1 MAP1A SH3BGR ADCY5

1.63e-051937357c7aa5e2124830d0fa1df11b6413ec6cf780aad0
ToppCelldroplet-Bladder-BLADDER-1m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH11 RSAD2 SPNS2 VASH1 COLGALT2

1.63e-0519373588cd7d0d0da5c776b49fc131f746fe5ad9676fb7
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORT1 MYH11 CALD1 SH3BGR ADCY5

1.63e-051937350266a4fdf436d83ec1d9392abba8c6ec5166970a
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH11 CALD1 MAP1A SH3BGR ADCY5

1.68e-05194735aaecde88bd54134a938e76cdf059c1c2653e4e77
ToppCellE18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TPM4 MYH11 CALD1 SH3BGR ZEB2

1.72e-051957356e875c83f838241b5fcaf4a3249b1408d74521dc
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH11 CALD1 MAP1A SH3BGR ADCY5

1.72e-0519573556e7cd980f8fc2dae842e6a7bd919d4b41cebbbb
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH11 CALD1 MAP1A SH3BGR ADCY5

1.72e-05195735a28a504c69bc4dda7de023e1b4ea4f62390b158e
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH11 CALD1 SH3BGR ALDH1B1 ADCY5

1.76e-051967355159d8625d80c20eb28157b2603c8bde9d377a35
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH11 CALD1 MAP1A SH3BGR ADCY5

1.76e-051967354740ef6e428f1ccc81fc98c3b868afd38ce60535
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH11 CALD1 SH3BGR ALDH1B1 ADCY5

1.76e-051967356b5b7dbcb2cce8a736e44145a01290905876a5e9
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH11 CALD1 MAP1A SH3BGR ADCY5

1.80e-051977351a6b2ca94a4634c24cd95481576c955b20000a5f
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FRMD4A MYO9B MCF2L2 VASH1 ZEB2

1.85e-05198735e125eb8aa57c172e5518874da1bd25998292f5e2
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FRMD4A MYO9B MCF2L2 VASH1 ZEB2

1.85e-051987350baeb8e2c199ff10bb5c829c523546af3c9227c1
ToppCellTransplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X

SORT1 MYH9 MYH11 CALD1 ADCY5

1.85e-0519873589986c7756541df364df516329d10775ba0e78a4
ToppCellCOVID-19_Mild|World / Disease condition and Cell class

MYH9 RSAD2 MYO9B ZEB2 DYNC1H1

1.85e-0519873561ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCelltumor_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass

SORT1 MYH9 MYH11 CALD1 SH3BGR

1.85e-05198735f540f464118edc0fb809ebcb813d0302e6952253
ToppCellcellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MYH11 CALD1 SH3BGR ALDH1B1 ADCY5

1.85e-05198735e9f434bfd072e590fe44d518057ee5aa653038f3
ToppCell390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells)

MYH11 CALD1 SH3BGR ALDH1B1 ADCY5

1.85e-05198735c82a151f9f1477d4a401457173b8d72af776c137
ToppCell390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells)

MYH11 CALD1 SH3BGR ALDH1B1 ADCY5

1.85e-05198735dc63b56bb6291e527b172d603569376286262845
ToppCellnormal_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass

MYH9 MYH11 CALD1 SH3BGR ADCY5

1.89e-05199735d65847ceb68a560798df3f73e6f838e7c3e38a1c
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

MYH11 CALD1 SYNE1 CNTLN ZEB2

1.89e-05199735e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCellTracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

MYH11 CALD1 SH3BGR ALDH1B1 ADCY5

1.89e-05199735056a28c36cd58dc695a5ae6f29b62135d6aad819
ToppCellTracheal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

MYH11 CALD1 SH3BGR ALDH1B1 ADCY5

1.89e-05199735534dcfe8b65ad92bb8d749d1c7036ad4807e09cd
ToppCellControl_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type

MYH11 CALD1 SYNE1 ADCY5 ZEB2

1.94e-05200735c5e051f1aac8dda376c342a9932785a23450e073
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

FRMD4A MYH11 CALD1 ADCY5 ZEB2

1.94e-05200735b5b5a32925f225610fe25a021a742d6397162863
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

MYH11 CALD1 SYNE1 ADCY5 ZEB2

1.94e-05200735f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCellLPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MYH11 CALD1 MAP1A SYNE1 ADCY5

1.94e-05200735a3a1e35934d676c39f917652e50c502cb2f613c1
ToppCellLPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MYH11 CALD1 SYNE1 ADCY5 ZEB2

1.94e-05200735b22cae282591d8dead9869c2adbb9632615f50f7
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

FRMD4A MYH11 CALD1 SYNE1 ADCY5

1.94e-05200735c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCellControl_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type

MYH11 CALD1 SYNE1 ADCY5 ZEB2

1.94e-052007355ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCellLPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type

MYH11 CALD1 MAP1A SYNE1 CNTLN

1.94e-05200735593bf6a7c557437db9a9249a5058a46014179ef6
ToppCellBronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FRMD4A MYO7A MYO9B ZEB2 LILRB4

1.94e-0520073578d75d381cb2b9a4c9eb7c32a07b014eaee39195
ToppCellLPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

MYH11 CALD1 SYNE1 ADCY5 ZEB2

1.94e-0520073567dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCellLPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type

FRMD4A MYH11 CALD1 SYNE1 ADCY5

1.94e-052007358c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCellLPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type

MYH11 CALD1 MAP1A SYNE1 ZEB2

1.94e-0520073502cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

MYH11 CALD1 SYNE1 ADCY5 ZEB2

1.94e-05200735dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCellControl_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type

MYH11 CALD1 SYNE1 ADCY5 ZEB2

1.94e-05200735b0866b497aa71d06cef25f9a335fa584e95fa7e0
ToppCellLPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MYH11 CALD1 SYNE1 ADCY5 ZEB2

1.94e-0520073577631c471cc5d453a749784f838cfa6408caf09b
ToppCellfacs-Skin-Anagen-3m-Myeloid|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RSAD2 ARHGAP30 ZEB2 LILRB4

8.98e-05143734250f60f06f262f00acd14b09b3ef90dbb9759336
ToppCellfacs-Skin-Anagen-3m-Myeloid-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RSAD2 ARHGAP30 ZEB2 LILRB4

8.98e-051437340c7c0d7ca040e87412295672cd1f065c0e941391
ToppCellfacs-Skin-Anagen-3m-Myeloid-macrophage|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RSAD2 ARHGAP30 ZEB2 LILRB4

8.98e-0514373427f4896276342758651fe7a80d7408ac5e1be9c0
ToppCellTCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

MYH11 CALD1 ALDH1B1 ADCY5

1.17e-04153734ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

TICRR MYH11 CALD1 ADCY5

1.23e-04155734cd7d95cbcad248670e531d80bb83c55e36ebc573
ToppCellLPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FRMD4A MYH11 CALD1 ADCY5

1.29e-04157734bfec34182f052cf1c0d847ba53ea335d4d1190de
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MYH9 SYNE1 ARHGAP30 CCDC168

1.35e-04159734bf8ff9251bcb64b2b9d6dd93461aec97659686ec
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CALD1 TLE2 ZEB2 ISY1

1.35e-04159734e812cbde59188924c6277c3feadf1a9592fa62a4
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CALD1 TLE2 ZEB2 ISY1

1.35e-041597342607b562903228274fbd96168ba826782fab0b53
ToppCellAdult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor

MYH11 CALD1 SH3BGR ADCY5

1.39e-04160734fd14dfeb7021a4b7299371854dc8fc1fd66c8dae
ToppCellRV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper

TPM4 MYH11 DDAH1 CALD1

1.42e-0416173447b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FRMD4A GARIN4 MCF2L2 LILRB4

1.49e-04163734a6e272e043859858084b8d4d96fa4ff9e6eca454
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FRMD4A CALD1 SYNE1 MCF2L2

1.52e-04164734f6a961fa2002da7d9679f32af99e1314c0593ef9
ToppCellfacs-Aorta-Heart-24m-Endothelial-coronary_vascular_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DDAH1 SPNS2 VASH1 NPEPL1

1.52e-041647345ee3729fab794d7acb172d14ec5d91aa1a61cd61
ToppCell356C-Myeloid-Monocyte-CD16+_Monocyte|356C / Donor, Lineage, Cell class and subclass (all cells)

BMI1 MYO9B SUPT5H LILRB4

1.56e-0416573435a6de30438de364ccca948fc932da541a69ef89
ToppCellChildren_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

MYH11 CALD1 KCNC2 ADCY5

1.56e-041657348a82e20c9b1156bb4bbc16f7785abb04458d671b
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 CALD1 MAP1A ZEB2

1.63e-04167734e228b8373ffd4436e6b944e26d0fadf3ac289b21
ToppCellPND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MYH11 CALD1 MAP1A SH3BGR

1.63e-04167734784776d1fcc098f84d3c2eca58fa56cb9428f434
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 CALD1 MAP1A ZEB2

1.63e-041677347cb1b11e8e24a10115e46ffbb74889e672a7a026
ToppCelldroplet-Lung-3m-Hematologic-myeloid-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RSAD2 ARHGAP30 ALDH1B1 LILRB4

1.63e-04167734d62d5dec30d006a9cc8f3bc5ccc578e10f105027
ComputationalActin cytoskeleton binding.

TPM4 MYH9 MYH11 CALD1

9.57e-0630494MODULE_524
ComputationalGenes in the cancer module 419.

TPM4 MYH9 MYH11 CALD1

1.60e-0534494MODULE_419
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

BDP1 MYH9 SYNE1 DYNC1H1

6.94e-0549494GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Drugpurealin

TPM4 MYH9 MYH11 MYO9B DYNC1H1

1.10e-0658725CID006419303
Diseasepulse pressure measurement

DHX15 CCDC71L CWF19L2 MYH11 DDAH1 INPP5B FURIN ZNF516 ADCY5 GVQW3 MADD

3.64e-0413926911EFO_0005763
DiseaseAntihypertensive use measurement

CCDC71L MYH11 MYO9B FURIN MADD

3.96e-04265695EFO_0009927
DiseaseOsteoporosis, Age-Related

TPM4 CCT2 ADCY5

4.00e-0461693C0001787
DiseasePost-Traumatic Osteoporosis

TPM4 CCT2 ADCY5

4.00e-0461693C0751406
DiseaseOsteoporosis, Senile

TPM4 CCT2 ADCY5

4.00e-0461693C0029459
DiseaseOsteoporosis

TPM4 CCT2 ADCY5

4.40e-0463693C0029456
DiseaseBirth Weight

XRCC1 ADCY5

4.82e-0414692C0005612
DiseaseDiuretic use measurement

CCDC71L TICRR CWF19L2 ZEB2

6.72e-04169694EFO_0009928
DiseaseCorneal astigmatism

DHX15 ZEB2 MADD

7.91e-0477693EFO_1002040
Diseasecardiovascular system disease (is_implicated_in)

DDAH1 GYS1

1.10e-0321692DOID:1287 (is_implicated_in)
Diseasecolorectal carcinoma (is_implicated_in)

BMI1 XRCC1

1.21e-0322692DOID:0080199 (is_implicated_in)
Diseaseurinary uromodulin measurement

MYO9B DCUN1D3 DYNC1H1

1.50e-0396693EFO_0005663
Diseasefasting blood glucose measurement, HOMA-B, fasting blood insulin measurement

ADCY5 MADD

1.56e-0325692EFO_0004465, EFO_0004466, EFO_0004469
DiseaseAutosomal dominant nonsyndromic hearing loss

MYH9 MYO7A

2.10e-0329692cv:C5779548

Protein segments in the cluster

PeptideGeneStartEntry
DLTRAGEEDGKDTRE

ERICH1

281

Q86X53
ATEEIDKDLEEAGRR

BDP1

921

A6H8Y1
GDKDDGFDRRVAFLE

AMIGO1

431

Q86WK6
DLDGELRSEKEGRDR

CDC5L

246

Q99459
REEQLFRSGEDDEVK

CNTLN

661

Q9NXG0
GDRADVDRAVKAARE

ALDH1B1

71

P30837
KEGREDVRDDARSGR

GVQW3

51

Q3ZCU0
DGAEEEREKLRGITD

CALHM1

281

Q8IU99
RGEKRKRDAEDDGEE

ANP32E

251

Q9BTT0
EERRGKGRAADELEA

ADCY5

161

O95622
GTDGKDRDRDRDRED

DHX15

21

O43143
RRYKDEREDAILEEG

DCUN1D3

96

Q8IWE4
SRVDGEDEEGKEDGR

AKAP8L

326

Q9ULX6
RRDVKREEGEAFARE

RAB2B

126

Q8WUD1
LDDGIDDERLRKEFS

PABPC1

301

P11940
ELDDRRRETEEKVGN

PARP15

136

Q460N3
DDEDLAAKRLGIEDA

KCNC2

181

Q96PR1
GKDYRKAEGEREEEG

MAP1A

1906

P78559
KAEGEREEEGRAEAP

MAP1A

1911

P78559
GEHDRKRLEDDEDRL

MADD

1356

Q8WXG6
GEFLDTKDRQAEEDR

LILRB4

381

Q8NHJ6
SAEGCKEGRERREKD

GARIN4

416

Q8IYT1
AEREARLARGEKEEE

ISY1

191

Q9ULR0
DDEEDEAGRQRASGK

KCNN1

71

Q92952
NEDRGEVADEDKRII

BMI1

111

P35226
LERGESSQGEKEERD

MCF2L2

1056

Q86YR7
LEKRLRAAEGDDAED

MICALL2

761

Q8IY33
RDGIIDKEDLRDTFA

MYLPF

41

Q96A32
VDVEEGDLGRDSKRR

NPEPL1

506

Q8NDH3
VSKAAERERLGEEEE

CWF19L2

641

Q2TBE0
AEERDRAEAEAREKE

MYH9

1461

P35579
EDEARAARDKEEIFG

PAF1

441

Q8N7H5
KGEEAELERLEREFA

FRMD4A

456

Q9P2Q2
EEDEGRGERTAFIKD

FURIN

776

P09958
TEDRDRGRDAVKREA

EIF4G1

1211

Q04637
DGRRDEELEEAGREM

INPP5B

231

P32019
IKREKEERGEAVDEG

DYNC1H1

2111

Q14204
EDEAQRRRKGKEDEG

DYNC1H1

2391

Q14204
RRRKGKEDEGEEAAS

DYNC1H1

2396

Q14204
RAEDGAGLEAREEKV

CCDC71L

26

Q8N9Z2
EDREGEEQGKEDRRG

CCDC168

4206

Q8NDH2
EDRRGAGQEKVDRED

CCDC168

4216

Q8NDH2
RARFVAERDSEDDGE

COLGALT2

26

Q8IYK4
DEDEEAAKDRRNIRA

GYS1

676

P13807
RSAKGEEVDVARAER

DDAH1

31

O94760
RLEEEEAAAEKEDRG

SPOUT1

56

Q5T280
SKARRIVSDGEDEDD

ERCC6L

1021

Q2NKX8
GRFRGRFEDEDEELE

PCGF6

71

Q9BYE7
AEGVREDEDKGQREK

ARHGAP30

791

Q7Z6I6
EEAADSGEIDRRLEK

SZRD1

11

Q7Z422
GEDEECGRVRDFVAK

SORT1

81

Q99523
DALREAERFVIGDEE

RSAD2

261

Q8WXG1
GERAVKYLEEGEAER

SYNE1

3771

Q8NF91
IFKAGADEERAETAR

CCT2

11

P78371
AGGAEEEEADAERRR

SPNS2

11

Q8IVW8
VDEERRSAAGSEKEE

SUPT5H

26

O00267
EARKADRESRYEEEE

SUPT16H

996

Q9Y5B9
AKRGDRDRALSEEQE

PHF24

231

Q9UPV7
DKERAEAERARLEAE

CALD1

261

Q05682
KYADERDRAEAEARE

MYH11

1466

P35749
EALAGDVAFDKDRRE

ZNF516

441

Q92618
DFKELDIAGDEDNRR

SH3BGR

96

P55822
EDLRVAAKLFDEEGR

UBN2

461

Q6ZU65
EEADRGAKRICDLRE

TICRR

1781

Q7Z2Z1
EDRGRREEEGDKRSS

ZFR2

631

Q9UPR6
DGERERREKAEGDVA

TPM4

36

P67936
RAFEEDQVAGRLKED

RRP9

101

O43818
ALEEEEEDGGRSRKA

TMC4

61

Q7Z404
HVEKEDGEARERDEI

SNW1

341

Q13573
KFRREEDGERAVAEL

U2AF1L4

116

Q8WU68
EIRKEAREAANGDSD

PRKDC

2006

P78527
ICSDEEEDEEKGGRR

UBN1

491

Q9NPG3
GDTEDELRRVAEQKE

XRCC1

486

P18887
EEREAAEREAREKGH

ZEB2

1086

O60315
DVERLGRDDFRKELE

VASH1

281

Q7L8A9
KEDRAGVEAEGSRVE

TLE2

171

Q04725
GFEDLERGRREMVEE

MYO7A

966

Q13402
EKEREALEAARAGAE

MYO9B

1056

Q13459